LINC01011

Across TCGA pan-cancer cohorts, LINC01011 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC01011’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01011 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01011 is over-expressed in tumor, although a few such as KICH and UCEC show the opposite, repressed pattern.

KIRC, KICH, and LIHC are the cancer types where LINC01011 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01011 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.699	<.001	12	view →
KICH	Female	II,III,IV	−1.578	<.001	11	view →
LIHC	Female	II,III,IV	+0.742	<.001	9	view →
COAD	Male	II,III,IV	+0.701	<.001	7	view →
CHOL	Male	All	+2.021	<.001	5	view →
KIRP	All	IV	+0.495	.016	4	view →
UCEC	All	All	−0.344	.026	4	view →
LUAD	All	All	+0.244	.003	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC01011–KIRC

Open the KIRC breakdown →